{"id":37108,"date":"2026-06-26T05:49:50","date_gmt":"2026-06-26T00:19:50","guid":{"rendered":"https:\/\/atsixty.com\/?p=37108"},"modified":"2026-06-26T05:50:59","modified_gmt":"2026-06-26T00:20:59","slug":"polycystic-ovary-syndrome-diagnosis-management","status":"publish","type":"post","link":"https:\/\/atsixty.com\/index.php\/obg\/polycystic-ovary-syndrome-diagnosis-management\/","title":{"rendered":"Polycystic Ovary Syndrome \u2014 Diagnosis &amp; Management"},"content":{"rendered":"\n\n\n<meta charset=\"UTF-8\">\n<meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\">\n<title>Morning Rounds \u00b7 PCOS \u2014 Diagnosis &amp; Management<\/title>\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Playfair+Display:ital,wght@0,400;0,600;0,700;1,400;1,600&#038;family=Source+Serif+4:ital,wght@0,300;0,400;0,600;1,400&#038;display=swap\" rel=\"stylesheet\">\n<style>\n#gyn03 *,#gyn03 *::before,#gyn03 *::after{box-sizing:border-box;margin:0;padding:0}\n#gyn03{\n  --ob:#4B3A6E;\n  --ob-light:#5F4D85;\n  --ob-pale:#EFE9F5;\n  --ob-dark:#362952;\n  --correct:#2D6B47;--correct-bg:#EAF6EF;--correct-border:#3A9960;\n  --wrong:#B83232;--wrong-bg:#FDF0F0;--wrong-border:#E53935;\n  --ink:#241B36;--ink-mid:#4A3D63;--ink-soft:#8A7FA0;\n  --line:#E0D8EC;--cream:#F8F6FB;--warm:#FCFBFD;\n  font-family:'Source Serif 4',Georgia,serif;\n  font-size:16px;color:var(--ink);background:var(--cream);\n  line-height:1.7;padding:0 0 64px;\n}\n#gyn03 .mr-header{background:var(--ob);color:#F3EFFA;padding:34px 24px 28px;text-align:center}\n#gyn03 .mr-eyebrow{font-size:0.68rem;letter-spacing:0.18em;text-transform:uppercase;font-weight:600;opacity:0.65;margin-bottom:10px}\n#gyn03 .mr-title{font-family:'Playfair Display',serif;font-size:1.75rem;font-weight:700;line-height:1.2;margin-bottom:4px}\n#gyn03 .mr-title em{font-style:italic;font-weight:400;opacity:0.88}\n#gyn03 .mr-subtitle{font-size:0.82rem;opacity:0.7;margin-top:8px;font-style:italic}\n#gyn03 .mr-chips{display:flex;justify-content:center;gap:10px;margin-top:18px;flex-wrap:wrap}\n#gyn03 .mr-chip{background:rgba(255,255,255,0.13);border:1px solid rgba(255,255,255,0.22);border-radius:20px;padding:4px 13px;font-size:0.73rem}\n#gyn03 .mr-sentinel{height:1px}\n#gyn03 .mr-progress{position:fixed;top:0;left:0;right:0;z-index:9999;background:var(--warm);border-bottom:1px solid var(--line);box-shadow:0 2px 12px rgba(36,27,54,0.08);padding:9px 16px;display:none}\n#gyn03 .mr-progress.visible{display:block}\n#gyn03 .mr-prog-inner{max-width:720px;margin:0 auto;display:flex;align-items:center;justify-content:center}\n#gyn03 .mr-pips{display:flex;align-items:center;justify-content:center}\n#gyn03 .mr-pip-wrap{display:flex;align-items:center}\n#gyn03 .mr-pip-line{width:28px;height:2px;background:var(--line);transition:background 0.35s}\n#gyn03 .mr-pip-line.done{background:var(--ob)}\n#gyn03 .mr-pip{width:28px;height:28px;border-radius:50%;border:2px solid var(--line);background:var(--warm);display:flex;align-items:center;justify-content:center;font-size:0.63rem;font-weight:700;color:var(--ink-soft);transition:all 0.3s;flex-shrink:0}\n#gyn03 .mr-pip.correct{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#gyn03 .mr-pip.wrong{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n#gyn03 .mr-body{max-width:720px;margin:0 auto;padding:0 16px}\n#gyn03 .mr-case{background:var(--warm);border:1px solid var(--line);border-left:4px solid var(--ob);border-radius:10px;margin:28px 0;overflow:hidden;box-shadow:0 1px 6px rgba(36,27,54,0.05)}\n#gyn03 .mr-case-top{padding:16px 20px 14px;display:flex;gap:14px;align-items:flex-start}\n#gyn03 .mr-num{font-family:'Playfair Display',serif;font-size:2.2rem;font-weight:700;color:var(--ob);opacity:0.16;line-height:1;margin-top:-2px;flex-shrink:0}\n#gyn03 .mr-meta{flex:1}\n#gyn03 .mr-tag{font-size:0.61rem;font-weight:700;letter-spacing:0.14em;text-transform:uppercase;color:var(--ob);opacity:0.75;margin-bottom:5px}\n#gyn03 .mr-stem{font-size:0.94rem;color:var(--ink);line-height:1.72}\n#gyn03 .mr-stem strong{font-weight:600}\n#gyn03 .mr-stem em{font-style:italic}\n#gyn03 .mr-rule{height:1px;background:var(--line);margin:0 20px}\n#gyn03 .mr-opts{padding:12px 20px 16px;display:flex;flex-direction:column;gap:8px}\n#gyn03 .mr-opt{display:flex;align-items:flex-start;gap:11px;padding:10px 14px;border:1.5px solid var(--line);border-radius:8px;cursor:pointer;background:var(--warm);transition:border-color 0.15s,background 0.15s;-webkit-tap-highlight-color:transparent}\n#gyn03 .mr-opt:hover{border-color:var(--ob);background:var(--ob-pale)}\n#gyn03 .mr-opt.locked{cursor:default}\n#gyn03 .mr-opt.locked:hover{border-color:var(--line);background:var(--warm)}\n#gyn03 .mr-opt.correct{border-color:var(--correct-border);background:var(--correct-bg);cursor:default}\n#gyn03 .mr-opt.correct:hover{border-color:var(--correct-border);background:var(--correct-bg)}\n#gyn03 .mr-opt.wrong{border-color:var(--wrong-border);background:var(--wrong-bg);cursor:default}\n#gyn03 .mr-opt.wrong:hover{border-color:var(--wrong-border);background:var(--wrong-bg)}\n#gyn03 .mr-opt.dimmed{opacity:0.35;cursor:default}\n#gyn03 .mr-opt.dimmed:hover{border-color:var(--line);background:var(--warm)}\n#gyn03 .mr-ltr{flex-shrink:0;width:20px;height:20px;border-radius:50%;border:1.5px solid var(--line);display:flex;align-items:center;justify-content:center;font-size:0.62rem;font-weight:700;color:var(--ink-soft);margin-top:2px;transition:all 0.15s}\n#gyn03 .mr-opt.correct .mr-ltr{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#gyn03 .mr-opt.wrong .mr-ltr{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n#gyn03 .mr-opt-text{font-size:0.9rem;color:var(--ink-mid);line-height:1.58}\n#gyn03 .mr-opt.correct .mr-opt-text{color:var(--correct);font-weight:600}\n#gyn03 .mr-opt.wrong .mr-opt-text{color:var(--wrong)}\n#gyn03 .mr-exp{display:none;border-top:1px solid #d4c5e8;background:linear-gradient(180deg,#ece4f6 0%,#f4eff9 100%);padding:13px 20px 15px}\n#gyn03 .mr-exp-lbl{font-size:0.61rem;font-weight:700;letter-spacing:0.12em;text-transform:uppercase;color:#3F2D60;margin-bottom:6px}\n#gyn03 .mr-exp-text{font-size:0.86rem;color:#2A1F40;line-height:1.68}\n#gyn03 .mr-exp-text strong{font-weight:600}\n#gyn03 .mr-exp-text em{font-style:italic}\n#gyn03 .mr-img-wrap{margin-top:14px;background:var(--warm);border:1px solid var(--line);border-radius:8px;padding:14px;text-align:center}\n#gyn03 .mr-img-wrap figcaption{font-size:0.73rem;color:var(--ink-soft);font-style:italic;margin-top:8px;line-height:1.4}\n#gyn03 .mr-submit-wrap{text-align:center;padding:28px 16px 8px}\n#gyn03 .mr-btn{background:var(--ob);color:#F3EFFA;border:none;border-radius:8px;padding:13px 44px;font-family:'Playfair Display',serif;font-size:1rem;font-weight:700;cursor:pointer;box-shadow:0 2px 8px rgba(75,58,110,0.28)}\n#gyn03 .mr-btn:hover{background:var(--ob-dark)}\n#gyn03 .mr-score{display:none;background:var(--warm);border:1px solid var(--line);border-top:4px solid var(--ob);border-radius:10px;margin:24px 0 0;box-shadow:0 2px 12px rgba(36,27,54,0.08);overflow:hidden}\n#gyn03 .mr-score-in{padding:28px 24px;text-align:center}\n#gyn03 .mr-score-ey{font-size:0.66rem;letter-spacing:0.14em;text-transform:uppercase;color:var(--ink-soft);margin-bottom:12px;font-weight:600}\n#gyn03 .mr-ring{width:98px;height:98px;border-radius:50%;background:conic-gradient(var(--ob) 0%,var(--line) 0%);display:flex;align-items:center;justify-content:center;margin:0 auto 16px;position:relative}\n#gyn03 .mr-ring::before{content:'';position:absolute;width:76px;height:76px;border-radius:50%;background:var(--warm)}\n#gyn03 .mr-ring-in{position:relative;display:flex;flex-direction:column;align-items:center;line-height:1.2}\n#gyn03 .mr-ring-pct{font-family:'Playfair Display',serif;font-size:1.3rem;font-weight:700;color:var(--ob)}\n#gyn03 .mr-ring-sub{font-size:0.54rem;color:var(--ink-soft);text-transform:uppercase;letter-spacing:0.06em}\n#gyn03 .mr-score-title{font-family:'Playfair Display',serif;font-size:1.15rem;font-weight:700;color:var(--ink);margin-bottom:4px}\n#gyn03 .mr-score-net{font-size:0.9rem;color:var(--ob);font-weight:600;margin-bottom:4px}\n#gyn03 .mr-verdict{font-size:0.83rem;color:var(--ink-soft);font-style:italic;margin-bottom:18px;padding:0 12px}\n#gyn03 .mr-bands{display:flex;justify-content:center;gap:10px;flex-wrap:wrap}\n#gyn03 .mr-band{padding:5px 13px;border-radius:16px;font-size:0.78rem;font-weight:600}\n#gyn03 .mr-band-c{background:var(--correct-bg);color:var(--correct)}\n#gyn03 .mr-band-w{background:var(--wrong-bg);color:var(--wrong)}\n#gyn03 .mr-band-s{background:var(--ob-pale);color:var(--ob)}\n#gyn03 .mr-retry{display:block;margin:18px auto 4px;background:transparent;border:2px solid var(--ob);color:var(--ob);border-radius:8px;padding:9px 28px;font-family:'Playfair Display',serif;font-size:0.92rem;font-weight:700;cursor:pointer}\n#gyn03 .mr-retry:hover{background:var(--ob);color:#F3EFFA}\n@media(max-width:480px){#gyn03 .mr-title{font-size:1.4rem}#gyn03 .mr-num{font-size:1.7rem}#gyn03 .mr-stem{font-size:0.9rem}#gyn03 .mr-opt-text{font-size:0.86rem}}\n<\/style>\n\n<div id=\"gyn03\">\n\n  <div class=\"mr-header\">\n    <div class=\"mr-eyebrow\">Morning Rounds &middot; Gynaecology Series &middot; Round 03<\/div>\n    <div class=\"mr-title\">\n      Polycystic Ovary Syndrome &mdash;<br><em>Diagnosis &amp; Management<\/em>\n    <\/div>\n    <div class=\"mr-subtitle\">Five cases &middot; Rotterdam criteria, mechanism, red flags &amp; goal-directed therapy &middot; Trust your instinct<\/div>\n    <div class=\"mr-chips\">\n      <span class=\"mr-chip\">5 Cases<\/span>\n      <span class=\"mr-chip\">+4 \/ &minus;1 scoring<\/span>\n      <span class=\"mr-chip\">Options reshuffled<\/span>\n    <\/div>\n  <\/div>\n\n  <div class=\"mr-sentinel\" id=\"gyn03-sentinel\"><\/div>\n\n  <div class=\"mr-progress\" id=\"gyn03-progress\">\n    <div class=\"mr-prog-inner\">\n      <div class=\"mr-pips\" id=\"gyn03-pips\"><\/div>\n    <\/div>\n  <\/div>\n\n  <div class=\"mr-body\">\n    <div id=\"gyn03-cases\"><\/div>\n    <div class=\"mr-submit-wrap\">\n      <button class=\"mr-btn\" id=\"gyn03-submit\">Submit for Debrief<\/button>\n    <\/div>\n    <div class=\"mr-score\" id=\"gyn03-score\">\n      <div class=\"mr-score-in\">\n        <div class=\"mr-score-ey\">Round Complete<\/div>\n        <div class=\"mr-ring\" id=\"gyn03-ring\">\n          <div class=\"mr-ring-in\">\n            <span class=\"mr-ring-pct\" id=\"gyn03-pct\">0%<\/span>\n            <span class=\"mr-ring-sub\">net<\/span>\n          <\/div>\n        <\/div>\n        <div class=\"mr-score-title\">Your Debrief<\/div>\n        <div class=\"mr-score-net\" id=\"gyn03-net\"><\/div>\n        <div class=\"mr-verdict\" id=\"gyn03-verdict\"><\/div>\n        <div class=\"mr-bands\">\n          <span class=\"mr-band mr-band-c\" id=\"gyn03-ct-c\"><\/span>\n          <span class=\"mr-band mr-band-w\" id=\"gyn03-ct-w\"><\/span>\n          <span class=\"mr-band mr-band-s\" id=\"gyn03-ct-s\"><\/span>\n        <\/div>\n        <button class=\"mr-retry\" id=\"gyn03-retry\">&#8635; New Round<\/button>\n      <\/div>\n    <\/div>\n  <\/div>\n\n<\/div><!-- end #gyn03 -->\n\n<script>\n(function () {\n  'use strict';\n\n  var NS    = 'gyn03';\n  var TOTAL = 5;\n  var MAX   = 20;\n  var LTRS  = ['A','B','C','D'];\n\n  var QS = [\n\n    {\n      id:      1,\n      tag:     'PCOS &mdash; Rotterdam Diagnostic Criteria',\n      stem:    'A 22-year-old presents with irregular cycles every 45&ndash;90 days since menarche, mild hirsutism, and a pelvic ultrasound showing multiple small follicles in both ovaries. Her LH:FSH ratio is normal, and thyroid and prolactin levels are normal. Does she meet diagnostic criteria for PCOS, and on what basis?',\n      correct: 'Yes &mdash; by Rotterdam criteria, PCOS needs any two of three features (oligo\/anovulation, hyperandrogenism, polycystic ovarian morphology) after excluding other causes; she has oligo-anovulation and hirsutism, satisfying two criteria, and a normal LH:FSH ratio does not exclude this since it isn\\'t a required component',\n      opts: [\n        'Yes &mdash; by Rotterdam criteria, PCOS needs any two of three features (oligo\/anovulation, hyperandrogenism, polycystic ovarian morphology) after excluding other causes; she has oligo-anovulation and hirsutism, satisfying two criteria, and a normal LH:FSH ratio does not exclude this since it isn\\'t a required component',\n        'No &mdash; a diagnosis of PCOS additionally requires an elevated LH:FSH ratio above 2:1 as an essential biochemical criterion within the Rotterdam definition, and since her ratio is normal, the diagnosis cannot be made despite the other two features already being present',\n        'No &mdash; all three Rotterdam features (oligo-anovulation, hyperandrogenism, and polycystic ovarian morphology) must be present simultaneously to diagnose PCOS, and since her presentation does not explicitly confirm biochemical hyperandrogenism alongside the clinical hirsutism, the criteria are not yet met',\n        'Yes &mdash; but the diagnosis additionally requires demonstrating insulin resistance on an oral glucose tolerance test, since insulin resistance is considered a core diagnostic criterion within the Rotterdam definition rather than an associated metabolic feature seen in many cases'\n      ],\n      exp:     'The <strong>Rotterdam criteria<\/strong> require any <strong>two of three<\/strong> features &mdash; oligo\/anovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound &mdash; once other causes (thyroid dysfunction, hyperprolactinaemia, non-classic CAH) are excluded. She has oligo-anovulation and hirsutism: two of three, diagnosis met. <br><br>An <strong>elevated LH:FSH ratio<\/strong> was once considered suggestive but is <strong>not part of the Rotterdam criteria<\/strong> &mdash; a normal ratio neither confirms nor excludes the diagnosis. Requiring <strong>all three features<\/strong> describes the older NIH criteria, not Rotterdam, which deliberately allows any two. And <strong>insulin resistance<\/strong>, while common in PCOS and clinically relevant for management, is an associated metabolic feature, not one of the three diagnostic criteria itself.',\n      imgId:   null\n    },\n\n    {\n      id:      2,\n      tag:     'PCOS &mdash; Hyperandrogenism Mechanism',\n      stem:    'In PCOS, excess ovarian androgen production is primarily driven by which mechanism?',\n      correct: 'Relatively elevated LH (compared to FSH) stimulates theca cell androgen production, while peripheral insulin resistance and compensatory hyperinsulinaemia further amplify ovarian androgen synthesis and reduce hepatic SHBG production, raising free androgen levels',\n      opts: [\n        'Relatively elevated LH (compared to FSH) stimulates theca cell androgen production, while peripheral insulin resistance and compensatory hyperinsulinaemia further amplify ovarian androgen synthesis and reduce hepatic SHBG production, raising free androgen levels',\n        'Excess FSH drives granulosa cell androgen overproduction directly, with LH playing a negligible role in ovarian androgen synthesis in PCOS, making elevated FSH rather than LH the principal hormonal driver of the hyperandrogenic state',\n        'Androgen excess in PCOS originates primarily from increased adrenal androgen secretion rather than ovarian theca cell activity, with the ovaries contributing only a minor proportion of circulating androgens in most affected women',\n        'Hyperinsulinaemia raises hepatic SHBG production substantially, which paradoxically increases free androgen levels by saturating SHBG\\'s binding capacity despite higher total SHBG being produced as a result'\n      ],\n      exp:     'The core mechanism is <strong>relatively elevated LH<\/strong> driving theca cell androgen synthesis, compounded by <strong>insulin resistance<\/strong> &mdash; hyperinsulinaemia directly amplifies ovarian androgen production and, critically, <strong>suppresses hepatic SHBG synthesis<\/strong>, so more androgen circulates unbound and biologically active. <br><br><strong>FSH<\/strong> is not the principal driver here &mdash; it is typically relatively low compared to LH in PCOS, not elevated. <strong>Adrenal<\/strong> androgen contribution exists in some women but the ovary, via theca cell LH-driven synthesis, is the primary source in classic PCOS. And the SHBG direction in the last distractor is inverted &mdash; insulin resistance <strong>lowers<\/strong> SHBG, it does not raise it; this is precisely the mechanism that increases free androgen, not a paradox layered on top of higher SHBG.',\n      imgId:   null\n    },\n\n    {\n      id:      3,\n      tag:     'PCOS Differential &mdash; Red Flags for Tumour\/CAH',\n      stem:    'A 26-year-old presents with a 6-month history of rapidly worsening hirsutism, deepening of her voice, and clitoromegaly. Should this be managed as PCOS, and why or why not?',\n      correct: 'No &mdash; rapid onset and severity of virilising features (voice change, clitoromegaly) over months, rather than the gradual hirsutism typical of PCOS since adolescence, should prompt evaluation for an androgen-secreting tumour or non-classic congenital adrenal hyperplasia before attributing this to PCOS',\n      opts: [\n        'No &mdash; rapid onset and severity of virilising features (voice change, clitoromegaly) over months, rather than the gradual hirsutism typical of PCOS since adolescence, should prompt evaluation for an androgen-secreting tumour or non-classic congenital adrenal hyperplasia before attributing this to PCOS',\n        'Yes &mdash; hirsutism and virilising features of any severity and tempo of onset fall within the recognised spectrum of PCOS presentations, so rapid progression over a few months alone does not warrant additional investigation beyond a standard PCOS workup here',\n        'No &mdash; but the appropriate next step is simply to repeat pelvic ultrasound for polycystic ovarian morphology, since ultrasound findings alone are generally sufficient to distinguish PCOS from an androgen-secreting tumour in a case presenting this way',\n        'Yes &mdash; clitoromegaly specifically is a recognised and fairly common finding in classic PCOS, occurring in a substantial proportion of affected women as part of the chronic hyperandrogenism that accumulates gradually over years in this condition'\n      ],\n      exp:     '<strong>Rapid-onset, severe virilisation<\/strong> &mdash; voice deepening, clitoromegaly, over months rather than years &mdash; is a textbook red flag for an <strong>androgen-secreting tumour<\/strong> (ovarian or adrenal) or <strong>non-classic CAH<\/strong>, not PCOS, which classically presents with slowly progressive hirsutism since adolescence. <br><br>Treating \"any severity and tempo\" as within the PCOS spectrum misses the single most important discriminator in hyperandrogenism cases &mdash; <strong>tempo of onset<\/strong>. <strong>Ultrasound alone<\/strong> cannot reliably distinguish a tumour from PCOS here; this needs androgen levels (testosterone, DHEAS) and often imaging beyond pelvic ultrasound. And <strong>clitoromegaly<\/strong> is not a typical PCOS finding at all &mdash; its presence itself is part of why this case should not be labelled PCOS.',\n      imgId:   null\n    },\n\n    {\n      id:      4,\n      tag:     'PCOS &mdash; Long-Term Risk &amp; Endometrial Protection',\n      stem:    'A 30-year-old with PCOS has chronic anovulation and has not had a period in 4 months, with no current desire for pregnancy. What long-term risk does this pattern carry, and what does management need to specifically address?',\n      correct: 'Chronic anovulation causes prolonged unopposed oestrogen exposure of the endometrium, carrying a risk of endometrial hyperplasia and, if unaddressed for years, endometrial cancer; management should ensure regular withdrawal bleeding via cyclical progestins, a COCP, or a levonorgestrel IUS rather than leaving cycles unmonitored',\n      opts: [\n        'Chronic anovulation causes prolonged unopposed oestrogen exposure of the endometrium, carrying a risk of endometrial hyperplasia and, if unaddressed for years, endometrial cancer; management should ensure regular withdrawal bleeding via cyclical progestins, a COCP, or a levonorgestrel IUS rather than leaving cycles unmonitored',\n        'The primary long-term risk in this pattern is ovarian hyperstimulation from accumulated unruptured follicles building up over successive anovulatory cycles, and management should focus on monitoring ovarian size by serial ultrasound rather than on endometrial protection',\n        'Since she is not currently trying to conceive, the absence of withdrawal bleeding for several months at a time can reasonably be left unmanaged, as endometrial risk in PCOS is primarily considered relevant only once a woman is actively attempting pregnancy',\n        'The main long-term risk from this anovulatory pattern is premature ovarian insufficiency from accelerated follicular depletion over time, and management should prioritise fertility preservation counselling ahead of any endometrial intervention at this stage'\n      ],\n      exp:     'Chronic anovulation in PCOS means <strong>unopposed oestrogen<\/strong> acts on the endometrium for months at a stretch without the cyclical progesterone that normally triggers shedding &mdash; this is the well-established mechanism behind the long-term <strong>endometrial hyperplasia and cancer risk<\/strong> in PCOS. Management should ensure regular withdrawal bleeding regardless of fertility intentions, via cyclical progestins, a COCP, or an LNG-IUS. <br><br>\"Ovarian hyperstimulation\" describes an iatrogenic complication of fertility treatment, not a spontaneous risk of anovulatory PCOS itself. <strong>Endometrial risk is not contingent on pregnancy intentions<\/strong> &mdash; it applies regardless of whether she is trying to conceive, so deferring management until fertility becomes relevant is the wrong call. And the anovulatory pattern here reflects ongoing follicular activity without ovulation, not <strong>follicular depletion<\/strong> &mdash; premature ovarian insufficiency is a different process altogether.',\n      imgId:   null\n    },\n\n    {\n      id:      5,\n      tag:     'PCOS Management &mdash; Fertility vs Non-Fertility Goals',\n      stem:    'Two women with PCOS are being managed: one wants to conceive within the next few months, the other wants cycle regulation and is not seeking pregnancy. What is the appropriate first-line approach for each?',\n      correct: 'For the woman seeking pregnancy, first-line management is lifestyle modification plus an ovulation induction agent such as letrozole; for the other, first-line management is a combined oral contraceptive for cycle regulation and endometrial protection, with metformin as an adjunct rather than primary therapy for either',\n      opts: [\n        'For the woman seeking pregnancy, first-line management is lifestyle modification plus an ovulation induction agent such as letrozole; for the other, first-line management is a combined oral contraceptive for cycle regulation and endometrial protection, with metformin as an adjunct rather than primary therapy for either',\n        'Both women should be started on combined oral contraceptives as first-line therapy regardless of their fertility intentions, since COCPs provide the most comprehensive control of the overall PCOS phenotype irrespective of whether pregnancy is currently being actively pursued',\n        'Metformin should be offered as first-line therapy to both women ahead of any other intervention, since it addresses the underlying insulin resistance considered central to PCOS regardless of whether ovulation induction or cycle regulation is the immediate clinical goal',\n        'For the woman seeking pregnancy, first-line management should be gonadotropin injections to induce ovulation directly, reserving oral agents like letrozole or clomiphene only for cases where injectable gonadotropins have already been tried and failed'\n      ],\n      exp:     'Management in PCOS is <strong>goal-directed<\/strong>. For the woman seeking pregnancy: lifestyle modification plus an oral <strong>ovulation induction agent<\/strong> (letrozole, now generally preferred over clomiphene) is first-line. For the woman not seeking pregnancy: a <strong>COCP<\/strong> (or cyclical progestin) is first-line for cycle regulation, hyperandrogenism control, and endometrial protection. <strong>Metformin<\/strong> plays an adjunctive role for metabolic features in either group, not as primary therapy ahead of the goal-specific options. <br><br>A <strong>COCP is contraceptive<\/strong> and would work against the pregnancy-seeking woman\\'s stated goal, so it cannot be first-line for both regardless of phenotype control. And <strong>gonadotropin injections<\/strong> are escalation therapy reserved for when oral agents fail &mdash; starting there skips the appropriate first-line step and its lower cost, complexity, and multiple-pregnancy risk profile.',\n      imgId:   null\n    }\n\n  ];\n\n  var answers  = {};\n  var answered = 0;\n  var shuffled = {};\n  var done     = false;\n\n  function byId(id) { return document.getElementById(id); }\n  function gid(suffix) { return byId(NS + '-' + suffix); }\n\n  function shuffleArr(arr) {\n    var a = arr.slice(), i, j, tmp;\n    for (i = a.length - 1; i > 0; i--) {\n      j = Math.floor(Math.random() * (i + 1));\n      tmp = a[i]; a[i] = a[j]; a[j] = tmp;\n    }\n    return a;\n  }\n\n  function countVal(val) {\n    var k, n = 0;\n    for (k in answers) {\n      if (answers.hasOwnProperty(k) && answers[k] === val) n++;\n    }\n    return n;\n  }\n\n  function buildPips() {\n    var cont = gid('pips'), i, q, wLine, wPip, line, pip;\n    cont.innerHTML = '';\n    for (i = 0; i < QS.length; i++) {\n      q = QS[i];\n      if (i > 0) {\n        wLine = document.createElement('div');\n        wLine.className = 'mr-pip-wrap';\n        line = document.createElement('div');\n        line.className = 'mr-pip-line';\n        line.id = NS + '-pl' + q.id;\n        wLine.appendChild(line);\n        cont.appendChild(wLine);\n      }\n      wPip = document.createElement('div');\n      wPip.className = 'mr-pip-wrap';\n      pip = document.createElement('div');\n      pip.className = 'mr-pip';\n      pip.id = NS + '-pip' + q.id;\n      pip.textContent = String(q.id);\n      wPip.appendChild(pip);\n      cont.appendChild(wPip);\n    }\n  }\n\n  function build() {\n    var cont, i, q, opts, card, top, numDiv, meta, tag, stem,\n        rule, optsDiv, expDiv, lbl, txt, imgDiv, imgSrc, j,\n        optEl, ltrSpan, txtSpan;\n\n    cont = gid('cases');\n    cont.innerHTML = '';\n    answers = {}; answered = 0; shuffled = {}; done = false;\n    gid('score').style.display = 'none';\n    buildPips();\n\n    for (i = 0; i < QS.length; i++) {\n      q = QS[i];\n      opts = shuffleArr(q.opts);\n      shuffled[q.id] = opts;\n\n      card = document.createElement('div');\n      card.className = 'mr-case';\n\n      top = document.createElement('div');\n      top.className = 'mr-case-top';\n\n      numDiv = document.createElement('div');\n      numDiv.className = 'mr-num';\n      numDiv.textContent = q.id < 10 ? '0' + q.id : String(q.id);\n\n      meta = document.createElement('div');\n      meta.className = 'mr-meta';\n\n      tag = document.createElement('div');\n      tag.className = 'mr-tag';\n      tag.innerHTML = q.tag;\n\n      stem = document.createElement('div');\n      stem.className = 'mr-stem';\n      stem.innerHTML = q.stem;\n\n      meta.appendChild(tag);\n      meta.appendChild(stem);\n      top.appendChild(numDiv);\n      top.appendChild(meta);\n      card.appendChild(top);\n\n      rule = document.createElement('div');\n      rule.className = 'mr-rule';\n      card.appendChild(rule);\n\n      optsDiv = document.createElement('div');\n      optsDiv.className = 'mr-opts';\n\n      for (j = 0; j < opts.length; j++) {\n        optEl = document.createElement('div');\n        optEl.className = 'mr-opt';\n        optEl.id = NS + '-o' + q.id + '-' + j;\n        optEl.setAttribute('role', 'button');\n        optEl.setAttribute('tabindex', '0');\n\n        ltrSpan = document.createElement('span');\n        ltrSpan.className = 'mr-ltr';\n        ltrSpan.textContent = LTRS[j];\n\n        txtSpan = document.createElement('span');\n        txtSpan.className = 'mr-opt-text';\n        txtSpan.innerHTML = opts[j];\n\n        optEl.appendChild(ltrSpan);\n        optEl.appendChild(txtSpan);\n        optsDiv.appendChild(optEl);\n\n        (function (qid, oi) {\n          optEl.addEventListener('click', function () { pick(qid, oi); });\n        }(q.id, j));\n      }\n      card.appendChild(optsDiv);\n\n      expDiv = document.createElement('div');\n      expDiv.className = 'mr-exp';\n      expDiv.id = NS + '-exp' + q.id;\n\n      lbl = document.createElement('div');\n      lbl.className = 'mr-exp-lbl';\n      lbl.textContent = 'Debrief';\n\n      txt = document.createElement('div');\n      txt.className = 'mr-exp-text';\n      txt.innerHTML = q.exp;\n\n      expDiv.appendChild(lbl);\n      expDiv.appendChild(txt);\n\n      if (q.imgId) {\n        imgSrc = byId(q.imgId);\n        if (imgSrc) {\n          imgDiv = document.createElement('div');\n          imgDiv.innerHTML = imgSrc.innerHTML;\n          expDiv.appendChild(imgDiv);\n        }\n      }\n\n      card.appendChild(expDiv);\n      cont.appendChild(card);\n    }\n  }\n\n  function pick(qid, oi) {\n    var q, opts, i, el, correct;\n    if (answers[qid] !== undefined || done) return;\n\n    q = null;\n    for (i = 0; i < QS.length; i++) {\n      if (QS[i].id === qid) { q = QS[i]; break; }\n    }\n    if (!q) return;\n\n    opts = shuffled[qid];\n    correct = (opts[oi] === q.correct);\n    answers[qid] = correct ? 'c' : 'w';\n    answered++;\n\n    for (i = 0; i < opts.length; i++) {\n      el = byId(NS + '-o' + qid + '-' + i);\n      if (opts[i] === q.correct) {\n        el.className = 'mr-opt correct locked';\n      } else if (i === oi) {\n        el.className = 'mr-opt wrong locked';\n      } else {\n        el.className = 'mr-opt dimmed locked';\n      }\n    }\n\n    byId(NS + '-exp' + qid).style.display = 'block';\n    byId(NS + '-pip' + qid).className = 'mr-pip ' + (correct ? 'correct' : 'wrong');\n\n    if (qid > 1) {\n      var pl = gid('pl' + qid);\n      if (pl) pl.className = 'mr-pip-line done';\n    }\n  }\n\n  function showScore() {\n    var c, w, s, net, pct, disp, verdicts, vi, sc;\n    if (done) return;\n    done = true;\n\n    c = countVal('c');\n    w = countVal('w');\n    s = TOTAL - answered;\n    net  = (c * 4) - w;\n    pct  = Math.max(0, Math.round((net \/ MAX) * 100));\n    disp = Math.min(100, Math.max(0, pct));\n\n    gid('ring').style.background =\n      'conic-gradient(#4B3A6E ' + disp + '%, #E0D8EC 0%)';\n\n    gid('pct').textContent = pct + '%';\n    gid('net').textContent = 'Net Score: ' + net + ' \/ ' + MAX;\n\n    verdicts = [\n      [5, 'Clean sweep \\u2014 Rotterdam logic and goal-directed management both locked in.'],\n      [4, 'Strong round \\u2014 one mechanism or red-flag distinction to revisit.'],\n      [3, 'Solid base \\u2014 the debrief will sharpen the diagnostic-criteria and tempo-of-onset points.'],\n      [2, 'Halfway there \\u2014 review the missed cases carefully.'],\n      [0, 'PCOS rewards close re-reading \\u2014 the Rotterdam two-of-three rule is the one to watch.']\n    ];\n    gid('verdict').textContent = verdicts[4][1];\n    for (vi = 0; vi < verdicts.length; vi++) {\n      if (c >= verdicts[vi][0]) {\n        gid('verdict').innerHTML = verdicts[vi][1];\n        break;\n      }\n    }\n\n    gid('ct-c').textContent = '\\u2705 ' + c + ' Correct';\n    gid('ct-w').textContent = '\\u274C ' + w + ' Wrong';\n    gid('ct-s').textContent = '\\u23ED ' + s + ' Skipped';\n\n    sc = gid('score');\n    sc.style.display = 'block';\n    sc.scrollIntoView({ behavior: 'smooth', block: 'center' });\n  }\n\n  function tryInit() {\n    var sentinel = document.getElementById(NS + '-sentinel');\n    var submit   = document.getElementById(NS + '-submit');\n    var retry    = document.getElementById(NS + '-retry');\n    if (!sentinel || !submit || !retry) {\n      setTimeout(tryInit, 80);\n      return;\n    }\n    submit.addEventListener('click', showScore);\n    retry.addEventListener('click', function () {\n      build();\n      window.scrollTo(0, 0);\n    });\n    var bar = document.getElementById(NS + '-progress');\n    if (bar && window.IntersectionObserver) {\n      new IntersectionObserver(function (entries) {\n        bar.className = entries[0].isIntersecting ? 'mr-progress' : 'mr-progress visible';\n      }, { threshold: 0 }).observe(sentinel);\n    }\n    build();\n  }\n\n  tryInit();\n\n}());\n<\/script>\n\n\n\n","protected":false},"excerpt":{"rendered":"<p>Morning Rounds \u00b7 PCOS \u2014 Diagnosis &amp; Management Morning Rounds &middot; Gynaecology Series &middot; Round 03 Polycystic Ovary Syndrome &mdash;Diagnosis &amp; Management Five cases &middot; Rotterdam criteria, mechanism, red flags &amp; goal-directed therapy &middot; Trust your instinct 5 Cases +4 \/ &minus;1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief &#8635;&hellip;&nbsp;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[74,55],"tags":[82,93,83],"class_list":["post-37108","post","type-post","status-publish","format-standard","hentry","category-morning-rounds","category-obg","tag-cms","tag-gynaecology","tag-neet-pg"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Polycystic Ovary Syndrome \u2014 Diagnosis &amp; Management - atsixty<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atsixty.com\/index.php\/obg\/polycystic-ovary-syndrome-diagnosis-management\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Polycystic Ovary Syndrome \u2014 Diagnosis &amp; Management - atsixty\" \/>\n<meta property=\"og:description\" content=\"Morning Rounds \u00b7 PCOS \u2014 Diagnosis &amp; Management Morning Rounds &middot; Gynaecology Series &middot; Round 03 Polycystic Ovary Syndrome &mdash;Diagnosis &amp; Management Five cases &middot; Rotterdam criteria, mechanism, red flags &amp; goal-directed therapy &middot; Trust your instinct 5 Cases +4 \/ &minus;1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief &#8635;&hellip;&nbsp;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atsixty.com\/index.php\/obg\/polycystic-ovary-syndrome-diagnosis-management\/\" \/>\n<meta property=\"og:site_name\" content=\"atsixty\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-26T00:19:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-26T00:20:59+00:00\" \/>\n<meta name=\"author\" content=\"Avi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Avi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/polycystic-ovary-syndrome-diagnosis-management\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/polycystic-ovary-syndrome-diagnosis-management\\\/\"},\"author\":{\"name\":\"Avi\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"headline\":\"Polycystic Ovary Syndrome \u2014 Diagnosis &amp; Management\",\"datePublished\":\"2026-06-26T00:19:50+00:00\",\"dateModified\":\"2026-06-26T00:20:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/polycystic-ovary-syndrome-diagnosis-management\\\/\"},\"wordCount\":56,\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"keywords\":[\"CMS\",\"Gynaecology\",\"NEET-PG\"],\"articleSection\":[\"Morning Rounds\",\"OBG\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/polycystic-ovary-syndrome-diagnosis-management\\\/\",\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/polycystic-ovary-syndrome-diagnosis-management\\\/\",\"name\":\"Polycystic Ovary Syndrome \u2014 Diagnosis &amp; Management - atsixty\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\"},\"datePublished\":\"2026-06-26T00:19:50+00:00\",\"dateModified\":\"2026-06-26T00:20:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/polycystic-ovary-syndrome-diagnosis-management\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/polycystic-ovary-syndrome-diagnosis-management\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/polycystic-ovary-syndrome-diagnosis-management\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/atsixty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Polycystic Ovary Syndrome \u2014 Diagnosis &amp; Management\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\",\"url\":\"https:\\\/\\\/atsixty.com\\\/\",\"name\":\"At Sixty\",\"description\":\"The Option Taken\",\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atsixty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\",\"name\":\"Avi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"url\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"contentUrl\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"width\":200,\"height\":200,\"caption\":\"Avi\"},\"logo\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\"},\"sameAs\":[\"https:\\\/\\\/atsixty.com\"],\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/author\\\/avinaux\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Polycystic Ovary Syndrome \u2014 Diagnosis &amp; Management - atsixty","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atsixty.com\/index.php\/obg\/polycystic-ovary-syndrome-diagnosis-management\/","og_locale":"en_US","og_type":"article","og_title":"Polycystic Ovary Syndrome \u2014 Diagnosis &amp; Management - atsixty","og_description":"Morning Rounds \u00b7 PCOS \u2014 Diagnosis &amp; Management Morning Rounds &middot; Gynaecology Series &middot; Round 03 Polycystic Ovary Syndrome &mdash;Diagnosis &amp; Management Five cases &middot; Rotterdam criteria, mechanism, red flags &amp; goal-directed therapy &middot; Trust your instinct 5 Cases +4 \/ &minus;1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief &#8635;&hellip;&nbsp;","og_url":"https:\/\/atsixty.com\/index.php\/obg\/polycystic-ovary-syndrome-diagnosis-management\/","og_site_name":"atsixty","article_published_time":"2026-06-26T00:19:50+00:00","article_modified_time":"2026-06-26T00:20:59+00:00","author":"Avi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Avi","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atsixty.com\/index.php\/obg\/polycystic-ovary-syndrome-diagnosis-management\/#article","isPartOf":{"@id":"https:\/\/atsixty.com\/index.php\/obg\/polycystic-ovary-syndrome-diagnosis-management\/"},"author":{"name":"Avi","@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"headline":"Polycystic Ovary Syndrome \u2014 Diagnosis &amp; Management","datePublished":"2026-06-26T00:19:50+00:00","dateModified":"2026-06-26T00:20:59+00:00","mainEntityOfPage":{"@id":"https:\/\/atsixty.com\/index.php\/obg\/polycystic-ovary-syndrome-diagnosis-management\/"},"wordCount":56,"publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"keywords":["CMS","Gynaecology","NEET-PG"],"articleSection":["Morning Rounds","OBG"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/atsixty.com\/index.php\/obg\/polycystic-ovary-syndrome-diagnosis-management\/","url":"https:\/\/atsixty.com\/index.php\/obg\/polycystic-ovary-syndrome-diagnosis-management\/","name":"Polycystic Ovary Syndrome \u2014 Diagnosis &amp; Management - atsixty","isPartOf":{"@id":"https:\/\/atsixty.com\/#website"},"datePublished":"2026-06-26T00:19:50+00:00","dateModified":"2026-06-26T00:20:59+00:00","breadcrumb":{"@id":"https:\/\/atsixty.com\/index.php\/obg\/polycystic-ovary-syndrome-diagnosis-management\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atsixty.com\/index.php\/obg\/polycystic-ovary-syndrome-diagnosis-management\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/atsixty.com\/index.php\/obg\/polycystic-ovary-syndrome-diagnosis-management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/atsixty.com\/"},{"@type":"ListItem","position":2,"name":"Polycystic Ovary Syndrome \u2014 Diagnosis &amp; Management"}]},{"@type":"WebSite","@id":"https:\/\/atsixty.com\/#website","url":"https:\/\/atsixty.com\/","name":"At Sixty","description":"The Option Taken","publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atsixty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d","name":"Avi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","url":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","contentUrl":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","width":200,"height":200,"caption":"Avi"},"logo":{"@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png"},"sameAs":["https:\/\/atsixty.com"],"url":"https:\/\/atsixty.com\/index.php\/author\/avinaux\/"}]}},"_links":{"self":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/comments?post=37108"}],"version-history":[{"count":2,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37108\/revisions"}],"predecessor-version":[{"id":37110,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37108\/revisions\/37110"}],"wp:attachment":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/media?parent=37108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/categories?post=37108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/tags?post=37108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}